The American Diabetes Association has released a position statement on diabetes and hypertension. These are the strongest-graded recommendations:

• Most patients with diabetes and hypertension should be treated to a systolic blood pressure goal of <140 mmHg and a diastolic blood pressure goal of <90 mmHg.
• Patients with blood pressure ≥140/90 mmHg should have timely titration of pharmacologic therapy added to lifestyle therapy.
• Patients with BP ≥160/100 mmHg should have prompt initiation and timely titration of 2 drugs or a single-pill combination of drugs to reduce cardiovascular (CV) events.
• Treatment for hypertension should include drug classes demonstrated to reduce CV events in patients with diabetes: ACE inhibitors, angiotensin receptor blockers (ARBs), thiazide-like diuretics, or dihydropyridine calcium channel blockers. Multiple-drug therapy is usually required, but not ACE inhibitors and ARBs.
• An ACE inhibitor or ARB is recommended first-line treatment for hypertension in patients with diabetes and urine albumin-to-creatinine ratio ≥300 mg/g creatinine.